A Fluorescence-based Lymphocyte Assay Suitable for High-throughput Screening of Small Molecules

作者：Fouda Ahmed; Tahsini Mahasti; Khodayarian Fatemeh; Al nafisah Fatimah; Rafei Moutih^*

来源：Jove-Journal of Visualized Experiments, 2017, (121): e55199.

DOI：10.3791/55199

• Immunology
• Issue 121
• High-throughput screening
• phenotypic screening
• target-based screening
• drug discovery
• lymphocytes
• T cells
• B cells
• fluorescence
• green fluorescent protein
• Nur77(GFP) transgenic mice
• immunosuppression
• activation

High-throughput screening (HTS) is currently the mainstay for the identification of chemical entities capable of modulating biochemical reactions or cellular processes. With the advancement of biotechnologies and the high translational potential of small molecules, a number of innovative approaches in drug discovery have evolved, which explains the resurgent interest in the use of HTS. The oncology field is currently the most active research area for drug screening, with no major breakthrough made for the identification of new immunomodulatory compounds targeting transplantation-related complications or autoimmune ailments. Here, we present a novel in vitro murine fluorescent-based lymphocyte assay easily adapted for the identification of new immunomodulatory compounds. This assay uses T or B cells derived from a transgenic mouse, in which the Nur77 promoter drives GFP expression upon T-or B-cell receptor stimulation. As the GFP intensity reflects the activation/ transcriptional activity of the target cell, our assay defines a novel tool to study the effect of given compound(s) on cellular/biological responses. For instance, a primary screening was performed using 4,398 compounds in the absence of a "target hypothesis", which led to the identification of 160 potential hits displaying immunomodulatory activities. Thus, the use of this assay is suitable for drug discovery programs exploring large chemical libraries prior to further in vitro/in vivo validation studies.

• 出版日期2017-3